Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

AbbVie shares positive phase 3 results for migraine drug Qulipta

The impact of chronic migraines on patients can be debilitating

- PMLiVE

US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan

The Sackler family will pay the amount over 18 years to victims of addiction and US states

- PMLiVE

Should we stop talking about people as patients and start thinking of them as partners? After all, it is their physical and mental health and well-being

By David Williams

- PMLiVE

Harnessing the power of patient intelligence can redefine your success

By Su Smith

- PMLiVE

Impact That Matters

By Cath Brassington-Richards

- PMLiVE

Patient-centricity and how HCPs can help achieve better patient outcomes through collaboration

By Ingrid Martin

- PMLiVE

Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity

By Emily Mitchell

- PMLiVE

Mapping patient pathways – with a focus on patient-centricity

By Alison Dunlop

- PMLiVE

Mapping patient pathways with a focus on patient-centricity: the role of medical education

By David Noble

- PMLiVE

Charting patient pathways with precision for better healthcare

Making a healthcare system tick is like creating a Swiss watch – it requires patience, persistence and a sharp eye for detail

Increasing patient randomisation rate by 200% for a Top 5 global pharma

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

Innovative Trials

- PMLiVE

Creative Director, Europe appointment at Nucleus Global

We hear from Trevor Telo, Nucleus Global’s new Creative Director, Europe, about his experience and ambitions for the role

Nucleus Global

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links